Alteogen announces it has been granted a process patent for producing aflibercept

Jan 4, 2019

Alteogen announces it has been granted a process patent for producing aflibercept biosimilar, ALT-L9.  Alteogen reports the process improves the productivity and quality of large-scale production of fusion proteins.

Print Page Mail Article